ASCO GUIDELINES Bundle

Hepatitis B Screening Pocket Guide

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1398739

Contents of this Issue

Navigation

Page 4 of 7

Table 1. Definitions of HBV Reactivation and Outcomes Virologic outcomes Definitions HBV reactivation Chronic HBV • ≥2 log (100-fold) increase in HBV DNA compared to baseline or • HBV DNA ≥3 log (1,000) IU/mL if previously undetectable HBV DNA or • HBV DNA ≥4 log (10,000) IU/mL if baseline HBV DNA not available Past HBV • HBV DNA detectable • Reverse HBsAg seroconversion (HBsAg-negative to HBsAg-positive) Hepatitis flare ALT increase >3× baseline and >100 U/L Clinical outcomes Definitions HBV-associated hepatitis flare HBV reactivation plus hepatitis flare HBV-associated liver failure • Impaired synthetic function (total bilirubin >3 mg/dL or INR >1.5) or • Ascites or • Encephalopathy Death attributed to HBV reactivation Following HBV-associated liver failure Table 2. Interpretation of HBV Test Results HBV status Hepatitis B surface antigen (HBsAg) Hepatitis B core antibody (anti-HBc) Antibody to hepatitis B surface antigen (anti-HBs) Chronic HBV infection + + – Past HBV infection Resolved – + + Isolated core – + – anti-HBc is total Ig or IgG test.

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Hepatitis B Screening Pocket Guide